Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 38216400)

  • 1. Predictive and prognostic molecular biomarkers in lymphomas.
    Iorgulescu JB; Medeiros LJ; Patel KP
    Pathology; 2024 Mar; 56(2):239-258. PubMed ID: 38216400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A genetic profiling guideline to support diagnosis and clinical management of lymphomas.
    Sánchez-Beato M; Méndez M; Guirado M; Pedrosa L; Sequero S; Yanguas-Casás N; de la Cruz-Merino L; Gálvez L; Llanos M; García JF; Provencio M
    Clin Transl Oncol; 2024 May; 26(5):1043-1062. PubMed ID: 37672206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New developments in non-Hodgkin lymphoid malignancies.
    Ganapathi KA; Brown LE; Prakash S; Bhargava P
    Pathology; 2021 Apr; 53(3):349-366. PubMed ID: 33685720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Molecular abnormalities in lymphomas].
    Delsol G
    Bull Cancer; 2010 Nov; 97(11):1347-64. PubMed ID: 21084243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MRD Detection in B-Cell Non-Hodgkin Lymphomas Using Ig Gene Rearrangements and Chromosomal Translocations as Targets for Real-Time Quantitative PCR.
    Pott C; Brüggemann M; Ritgen M; van der Velden VHJ; van Dongen JJM; Kneba M
    Methods Mol Biol; 2019; 1956():199-228. PubMed ID: 30779036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [R.E.A.L. classification of non-Hodgkin lymphoma from the clinico-oncologic viewpoint].
    Meusers P; Brittinger G
    Praxis (Bern 1994); 1998 Jun; 87(23):793-800. PubMed ID: 9654985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An update on genetic aberrations in T-cell neoplasms.
    Parilla M; Quesada AE; Medeiros LJ; Thakral B
    Pathology; 2023 Apr; 55(3):287-301. PubMed ID: 36801152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical utility of recently identified diagnostic, prognostic, and predictive molecular biomarkers in mature B-cell neoplasms.
    Onaindia A; Medeiros LJ; Patel KP
    Mod Pathol; 2017 Oct; 30(10):1338-1366. PubMed ID: 28664939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The World Health Organization classification of malignant lymphoma: incidence and clinical prognosis in HTLV-1-endemic area of Fukuoka.
    Ohshima K; Suzumiya J; Kikuchi M
    Pathol Int; 2002 Jan; 52(1):1-12. PubMed ID: 11940200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution and ZAP-70 expression of WHO lymphoma categories in Shanxi, China: a review of 447 cases using a tissue microarray technique.
    Wang J; Young L; Win W; Taylor CR
    Appl Immunohistochem Mol Morphol; 2005 Dec; 13(4):323-32. PubMed ID: 16280661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathology consultation on intermediate-to-large B-cell lymphomas.
    Montgomery ND; Fedoriw Y
    Am J Clin Pathol; 2014 Mar; 141(3):305-17. PubMed ID: 24515757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ESMO consensus conference on malignant lymphoma: general perspectives and recommendations for prognostic tools in mature B-cell lymphomas and chronic lymphocytic leukaemia.
    Ladetto M; Buske C; Hutchings M; Dreyling M; Gaidano G; Le Gouill S; Luminari S; Pott C; Zamò A; Zucca E;
    Ann Oncol; 2016 Dec; 27(12):2149-2160. PubMed ID: 27701070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression profiles of MYC protein and MYC gene rearrangement in lymphomas.
    Chisholm KM; Bangs CD; Bacchi CE; Molina-Kirsch H; Cherry A; Natkunam Y
    Am J Surg Pathol; 2015 Mar; 39(3):294-303. PubMed ID: 25581730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive histopathological diagnostics of aggressive B-cell lymphomas based on the updated criteria of the World Health Organisation's 2017 classification.
    Szumera-Ciećkiewicz A; Rymkiewicz G; Grygalewicz B; Jesionek-Kupnicka D; Gruchała A; Ziarkiewicz-Wróblewska B; Gałązka K; Reszeć J; Borg K; Prochorec-Sobieszek M
    Pol J Pathol; 2018; 69(1):1-19. PubMed ID: 29895122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pathology of malignant lymphomas--clarity instead of confusion].
    Mueller-Garamvölgyi E; Perren A; Schmitt A
    Ther Umsch; 2010 Oct; 67(10):497-500. PubMed ID: 20886454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive genomic profiling of orbital and ocular adnexal lymphomas identifies frequent alterations in MYD88 and chromatin modifiers: new routes to targeted therapies.
    Cani AK; Soliman M; Hovelson DH; Liu CJ; McDaniel AS; Haller MJ; Bratley JV; Rahrig SE; Li Q; Briceño CA; Tomlins SA; Rao RC
    Mod Pathol; 2016 Jul; 29(7):685-97. PubMed ID: 27102345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetics and Diagnostic Approach to Lymphoblastic Leukemia/Lymphoma.
    Afkhami M; Ally F; Pullarkat V; Pillai RK
    Cancer Treat Res; 2021; 181():17-43. PubMed ID: 34626353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BCR-ABL1-like B-Lymphoblastic Leukemia/Lymphoma with FOXP1-ABL1 Rearrangement: Comprehensive Laboratory Identification Allowing Tyrosine Kinase Inhibitor Use.
    Yenamandra AK; Kaviany S; Borinstein SC; Friedman DL; Kovach AE
    Lab Med; 2019 Oct; 50(4):401-405. PubMed ID: 30938769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B-cell lymphomas with MYC/8q24 rearrangements and IGH@BCL2/t(14;18)(q32;q21): an aggressive disease with heterogeneous histology, germinal center B-cell immunophenotype and poor outcome.
    Li S; Lin P; Fayad LE; Lennon PA; Miranda RN; Yin CC; Lin E; Medeiros LJ
    Mod Pathol; 2012 Jan; 25(1):145-56. PubMed ID: 22002575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Grey zone lymphomas: limitations of the classification of aggressive B-cell lymphomas].
    Ott MM; Horn H; Rosenwald A; Ott G
    Pathologe; 2013 May; 34(3):225-32. PubMed ID: 23494279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.